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Abstract-Healthcare organizations are facing the challenge of
delivering high-quality services through effective process
management. There have been frequent changes of clinical
processes and increased interactions between different functional
units. To facilitate the dynamic and interactive processes in
healthcare organizations, an agent-based cognitive approach is
presented in this study. The emphasis is placed on dynamic
clinical and administrative process management, and knowledge
building as the foundation for process management. The
treatment of primary open angle glaucoma is used as an example
to demonstrate the effectiveness of approach for healthcare
process management.
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I. INTRODUCTION
In healthcare organizations, there are a variety ofprocesses,
such as hospital administration by managers, registration for
treatment by patients, test report generation by technicians, and
diagnosis decision making by doctors. There is a trend to view
health care in a multidisciplinary perspective, as numerous
interactions and cooperation take place across different
functional units in terms of information sharing, consultation,
and combined treatments. These interactive and collaborative
activities should be well organized and managed, without
which the efficiency of healthcare service cannot be easily
guaranteed. To meet these requirements, a process-oriented
and cooperation-supported healthcare system is needed,
especially with computer and information technology support
[19].
To facilitate healthcare process management, workflow
technology has been applied in a number of studies [14].
Workflow is defined as a process managed by a computer
program that assigns the work, passes it on, and tracks its
progress [1]. The main advantage ofusing workflow technique
is to help establish, maintain, modify or even reconstruct
business processes in various organizations. In the recent years,
organizational environments have been changing from
stable-and-closed to dynamic-and-open. Business processes are
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becoming increasingly complex and dynamic as they seek to
cope with a wide range ofinternal and external interactions and
changes. Traditional workflow technologies for process
management are often inadequate for complex and dynamic
situations due to the lack of flexibility and adaptability [17].
This change has also happened in the healthcare sector. Due to
newly discovered symptoms of a specific disease or need of
further diagnosis, pre-planned clinical schedules always
request adjustment; ad hoc changes of medical process are
needed during execution. Besides, to fulfill a simple task such
as gonioscopy for glaucoma diagnosis, cooperation among
different functional units is required. In sum, frequent changes
of clinical pathways and increased interactions between
different units have become a big challenge in healthcare
process management.
To develop a computer-based system that enables effective
process management in healthcare, an agent-based cognitive
approach is presented in this study. The term "agent" refers to a
piece ofsoftware that can perceive its environment through its
sensors and can act upon that environment through the
effectors [16]. A healthcare management unit has similar
characteristics with software agent, which has a set of goals
(e.g., treatment effects and costs), perceptions of the
environment (e.g., symptoms and records), and actions to take
(e.g., recommendations for test or treatment, and inquiry). The
highly dynamic and unpredictable nature of organizational
processes makes agent-based approaches appealing. Using
agent-based technology, we may decompose a complex process
into a number ofloosely coupled tasks and delegate the tasks to
a number of software agents, each of which works
autonomously and collaboratively in performing tasks and
managing the whole process [17].
In this study, an agent-based and process-oriented healthcare
system is developed. The system consists of three layers, the
agent layer for healthcare process management, the database
layer for maintenance of medical records and knowledge, and
the interface layer for human-computer interaction. The
emphasis is placed on dynamic clinical and administrative
process management, and knowledge building as the
foundation for process management. This agent-based and
process-oriented healthcare system distinguishes from other
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healthcare systems in terms of continuous awareness of the
healthcare environment, real-time dynamic decision making of
healthcare processes, and rule-based knowledge engineering.
The treatment ofprimary open angle glaucoma (POAG) is used
as an example to demonstrate the effectiveness of this
approach.
II. RELATED WORK
As an interdisciplinary field, the design and development of
clinical or healthcare systems have received increased
attentions. A number of studies have been conducted, such as
integrated healthcare enterprise frameworks,
computer-interpreted guideline implementation, and
workflow-supported healthcare management [14, 3, 18, 8].
Wirsz suggests an integrated healthcare platform be
formulized via combining mostly heterogeneous application
systems of different functional units [20]. Lenz and Reichert
identify and distinguish organizational processes and medical
treatment processes, and investigate how advanced process
management technology can improve IT support for healthcare
processes [10]. The workflow technique for process
management aims to separate the flow logic from the
application code. The adoption of workflow technique in
business applications seems promising, especially for end users
to design specific processes to facilitate their work [12, II].
However, most workflow systems often appear to be static and
lack of flexibility to offer run time changes [4]. Due to the
frequent changes and interactions in healthcare administration
and clinical pathways during treatments, there is an urgent
need to manage dynamic and collaborative processes in
healthcare environment.
III. SYSTEM ARCHITECTURE
To meet the requirements arising from dynamic processes
and cooperative functions in healthcare, an agent-based
healthcare process management system is presented with a
three-layer architecture.
A. Agent Layer
In the system, a group of software agents are proposed to
perform healthcare tasks . Various interactions take place
between the autonomous agents or between the agents and
human users including doctors, nurses, technicians, and
administrators (see Fig . I) . The design of software agents is
process-oriented, i.e., agents are able to execute tasks
according to process rules . What's more, process rules can be
edited in a graphical form, which makes it easy to specify and
update the rules. The details of each agent are elaborated as
follows.
Fig .l. Multi-Agent and Human-Agent Communication
Clinical Decision Agent (CDA) works with doctors. It
consists of three components: a knowledge base that captures
glaucoma knowledge into a set of rules for clinical diagnosis
decision making; a reasoning engine that generates diagnosis
decision or treatment recommendations based on patient
records and test results; and an interpreter that interprets the
decisions or recommendations generated by the computer.
Patient Management Agent (PMA) works with clinical
administrators and nurses, managing patient records and
coordinating treatment processes. It also interacts with other
agents for communication of patient records, test reports, and
treatment records throughout the healthcare process.
Medical Examination Agent (MEA) works with doctors,
medical technicians, or nurses, as well as communicates with
PMA and CDA throughout the medical examination process.
The medical examination process may go through several steps
including patient records access, test scheduling, notification
and reminder, and finally test report generation and delivery.
Ward Treatment Agent (WTA) works with doctors and
nurses, as well as communicates with PMA or CDA during the
inpatient treatment process. The activities include treatment
scheduling, notification and reminder, information inquiry,
and treatment report generation and delivery. The agent also
maintains the information oftreatment activities, progress, and
patient states during the treatment process.
Operation Agent (OA) works with doctors and nurses, as
well as communicates with PMA or CDA to manage the
operation process. The process may go through several steps
including patient records retrieval, operation scheduling,
notification and reminder, and operation report generation and
delivery.
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B. Database Stage
Medical information is stored in a database to support the
healthcare functions. The information includes patient records,
treatment records, examination records, diagnostic knowledge,
and treatment knowledge. Considering information security
and maintenance issue, different agents are associated with
different data, with different rights to access or update the data.
For example, PMA has the right to access patient records;
MEA maintains the examination reports of all patients ; OA
keeps the operation records; and WTA reserves the medication
records. The patient records, examination reports, operation
records, and medication records can be acquired via
communication with PMA, MEA, OA, and WTA respectively.
Differing from data records, knowledge for clinical and
administrative process management is more complicated;
relevant techniques and tools are used to capture and model the
knowledge into a set of rules or guidelines as discussed in
section IV and V.
C. Interface Layer
This layer supports various interactions between human
users (administrators, doctors, nurses, and medical technicians)
and the software agents. Different type of user may access and
interact with the system or software agents through relevant
interfaces. An ophthalmologist may interact with a CDA,
which is able to assist in diagnosis and treatment processes by
providing decision making support based on patient basic
information, diagnosis and medical status, test results, medical
prescription, surgical procedure, and so on. A MEA helps a
medical technician to manage test activities and reports, as well
as to communicate with PMA, CDA, and a doctor regarding
test arrangement and result report .
IV. COGNITIVE ApPROACH FOR PROCESS MANAGEMENT
To facilitate dynamic and interactive clinical processes, we
need to capture a large amount of information and knowledge
as the foundation for process management. In addition to
clinical information such as patient records and treatment data,
it is crucial to identify or set up the rules or guidelines as the
knowledge for diagnosis and treatment decision making and
clinical administration. To capture and represent the
knowledge in the system, ontology-based technology is adopted
in this study. Ontology is a way of knowledge engineering in
computer programs. It is used to describe a set of concepts
within a domain and the relationships between the concepts.
Ontology provides a structured vocabulary with computerized
specification of the vocabulary to model a domain. Using
ontology, the narrative paper based guidelines or rules are
encoded into computerized specifications.
To build the ontology, we use Protege [13, 15] as the
ontology representation tool. Protege is a free and open-source
platform that provides a suite of tools to construct domain
models and knowledge-based applications with ontology.
Protege can be customized to provide domain-friendly support
for creating knowledge models and entering data. Protege can
be further extended by way of a plug-in architecture and a
Java-based Application Programming Interface (API) for
building knowledge-based applications. In developing the
proposed system, we use Protege for knowledge building by
way of class modeling, goal and criteria building, clinical
algorithm construction.
In this study, we choose glaucoma treatment as an example
to demonstrate the proposed approach. Glaucoma is a leading
cause of blindness in most countries ; the irreparable loss of
vision by glaucoma requires lifelong health care. Meanwhile,
the disease ofglaucoma is well investigated; the process of the
treatment is documented as various kinds ofguidelines that can
be used as reference for knowledge building in this case. There
are many types ofglaucoma, from which we choose the primary
open angle glaucoma (POAG) for illustration.
A. Knowledge Modeling
We model the rules or guidelines for clinical
decision-making into clinical algorithms (see Fig. 2). Based on
the clinical algorithms, recommendations such as messages,
drugs, and referrals can be generated for diagnosis, treatment,
and other clinical process.
- - - - - - - - - _L - - - - - - - - - - __ ,
: : I
-------l-- -- --
Fig.2. Hierarchy ofclinical algorithm ontology
Each algorithm includes three nodes: scenario, decision,
and action. Scenarios are mutually exclusive entry points for
clinical algorithms, which exhibit unambiguous definition of
patient states. A scenario contains several major properties
called slots: a) the new encounter slot is used to enable/disable
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this scenario as a starting point; b) the precondition slot is to
qualify the scenario as a starting point; and c) the followed by
slot is a next step in the algorithm. A decision node contains: a)
a choice step (e.g., severe IOPl decrease <30%) which may
lead to more than one choice; or b) a case step which has an
evaluated expression to enable the execution of the next step
node. An action is a node with a rule in/out criteria slot (e.g., if
risk level = severe and lOP decrease >= 30%) and a defined
action slot (e.g., Filtration surgery) in forms of message, drug
recommendations, or referrals.
B. Clinical Process Management
The diagnosis and treatment process of glaucoma can be
divided into several steps: 1) differential diagnosis; 2) further
examination for establishing a baseline of intraocular pressure
(lOP); 3) setting up a goal of intraocular pressure (lOP); 4)
initial treatment; and 5) follow-up treatment.
Differential Diagnosis
In diagnosis period, comprehensive eye examination should
be carried out, which includes: slit lamp biomicroscopy,
Goldmann applanation tonometry (lOP), gonioscopy (to rule
out angle closure, second causes of glaucoma), indirect
ophthalmoscopy, and stereoscopic examination (for optic disc
changes and retinal nerve fiber layer (RNFL) loss). After this,
POAG or suspect can be differentiated via further examination.
A part of the rules for differential diagnosis are listed below.
IF (suspected Glaucoma)
THEN DO(complete slip lamp examination
AND gonioscopy AND lOP AND
disc and RNFL evaluation AND
automated perimetry)
IF (open angle and no secondary glaucoma)
IF (lOP >=22mmHg)
THEN DO(central corneal thickness (CCT)
AND diurnal variation test (DVT))
IF(disc change AND visual field defect)
THEN POAG AND DO(Humphrey
visual field (HVF) AND disc and
RNFL imaging)
ELSE IF (disc change AND normal visual
field)
THEN Pre-perimetric Glaucoma AND
DO(CCT AND blue on yellow
perimetry (SWAP) AND disc and
RNFL imaging)
ELSE IF (normal disc AND normal visual
field)
THEN Ocular Hypertension (OHT)
AND (CCT AND SWAP AND disc
and RNFL imaging)
ELSE IF (normal lOP AND disc change
AND visual field defect)
IF (lOP>21mmHg)
THEN POAG AND DO(Humphrey visual
field (HVF) AND disc and RNFL
imaging)
ELSE Normal Tension Glaucoma (NTG)
AND DO(Humphrey visual field (HVF)
AND disc and RNFL imaging)
Examinationfor Baseline Establishment
Once POAG is determined, further examinations are needed
for baseline establishment and initial treatment design. These
examinations include at least 24-h diurnal diviation test (DVT)
and central corneal thickness (CCT) test. In the examination,
visual field loss can be classified into three categories:
IF (A<-6dB) and (B<18points) and (C<10points)
and (D <15dB)
THEN Early defect
ELSE IF (A<-12dB) and (B<37points) and
(C<20points) and (D <OdB)
THEN Moderate defect
ELSE IF (A>-12dB) and (B>37points) and
(C>20points) and (D =OdB)
THEN Severe defect
ELSE Good condition
where A indicates mean deviation index (MD); Band C
indicate point number depressed below the 5% or 1% level on
the pattern deviation plot, respectively; and D indicates the
sensitivity ofno point in the central 5°.
Goal Setup
After establishing a good baseline, it is obliged to set up a
reasonable goal. The formula for target lOP rule is based on the
patient's reference lOP (Le., the mean of six separate lOP
measurements taken in the course of two baseline visits) and
reference visual field score (Le., the mean of at least 2 visual
fields taken during the two baseline visits). Below is the
formula is used by the Collaborative Initial Glaucoma
Treatment Study (CIGTS).
Target lOP =+J
( 1 - Reference IOP+Visual Field score) X Reference lOP100 (1)
where Visual Field Score ranges from 0 (no defect) to 20 (all
points showing a defect at the p<0.005 level).
Initial Treatment
Based on the goal established in STEP 3, an initial topical
therapy is carried out to lower the pressure. The guidelines for
the initial topical therapy are specified as follows:
Start the therapy in the worse eye first
IF (start topical therapy)
THEN choose first line medication
IF(met target lOP)
THEN continue and start in second eye
ELSE IF (not reduce lOP by at least 15% lOP or
severe side effects)
THEN choose second line medication
ELSE IF(reduce more than 15% from baseline)
THEN reserve and try second line
IF (second target lOP)
THEN continue and start in second eye
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ELSE IF (second cannot met target lOP but have
effect)
THEN try combination
ELSEstep5
During the initial topical therapy, medications are involved.
The rules for first line medication are listed below:
IF (cost-tolerable AND no inflammatory glaucoma)
THEN Prostaglandin analogues (PGA)
ELSE IF (target IOP=20% lOP reduction AND no
systemic beta-blocker AND no asthma
AND heart block)
THEN P-blocker
ELSE IF (target IOP>=30%)
IF (lOP reduction AND cost-tolerable AND no
inflammatory glaucoma)
THENPGA
ELSE IF (no infants and MAO inhibitors users)
THEN P-blocker+a-2 agonist
ELSE IF (no poor endothelial status)
THEN P-blocker+CAI
During the medications, the recommendation on dose usage
is made according to the equations . Suppose drug A decreases
outflow pressure by pA percentage, and drug B by pB
percentage, respectively.
IOP2 = IOPl- outflow pressure *pA (2)
IOP3 = IOP2 - [IOP2 - (IOPl - outflow pressure)*pB] (3)
where IOPI, lOn, and IOP3 indicate lOP measured before
drug A, after drug A and before drug B, and after drug B,
respectively. Based on (2), we can compare IOP2 and lOP goal
to see if drug B should be used after drug A; based on (3), we
may further compare IOP3 and lOP goal to estimate the topical
therapy effect. Some studies such as [7, 5] provided a rough
guide to the effect of various medications on the outflow
pressure.
Follow-up Treatment
In the initial treatment of POAG, the first step topical
therapy may not reach the initial intraocular pressure goal.
Therefore, treatment algorithm after topical therapy [9] should
be followed. Fig. 3 shows the modeling of this specific
algorithm in Protege. Pink circle indicates a scenario; yellow
polygon indicates a decision; and green square indicates an
action choice. They are linked by one direction arrow to show a
follow-up relation with each other and form an algorithm chart .
After implementation, the POAG treatment algorithm after
topical therapy is represented as an instance of Management
Algorithm Entity shown in Fig. 4. The pink circles, yellow
polygons, and green squares in Fig. 3 are mapped to three
subclasses (Scenario, Choice step, and Action Choice) of
Management Algorithm Entity, respectively in Fig. 4.
The treatment in this step starts from the scenario that the
lOP goal has not been reached after the initial topical therapy.
First, the evaluation of the risk level is required, within which
C/D ratio and field loss level examinations are executed to
collect data for evaluation. Based on the evaluation result, a
treatment pathway can be determined accordingly. There are
three different pathways representing mild disease, moderate
disease, and severe disease treatments. After the determination
ofthe pathway, a further choice is made based on lOP threshold,
which leads to different actions. For example, the mild level
risk combined with less than 20% decrease in lOP should take
laser action, and will lead to the follow-up phase scenario; the
mild level risk with more than 20% decrease in lOP will lead to
the follow up phase scenario directly. Similar processes are
taken in treatment ofmoderate and severe level risks, but with
more complexity in action choices like laser trabeculoplasty,
additional drops, carbonic anhydrate inhibitor (CAl) therapy,
or filtration surgery in different situations .
Fig.3. POAG treatment algorithm after topical therapy
Class Hierarchy
:THING
.. :SYSTEM-CLASS
... Guideline_Model_Entrty
.. Guideline
... Clinical_Algorrthm_Entrty
... I Management_Algorrthm_Entrty
Scenario (7)
... Decision
Case_step (1)
Choice_step (15)
... Action_like_step
Action_Choice (30)
.. Consurtation_Guideline_Entrty
Management_Diagram (2)
.. Connector_Relation
.. Action_Specification
.. Activrty _Specification
.. Goal_Entrty
.. Auxiliary _Entrty
FigA. Class hierarchy in Protege
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Fig.5. Sequence chart ofcommunicative acts
After the doctor selects an appropriate type of test, the medical
technician may work with the Medical Examination Agent to
settle the examination schedule and inform both the doctor and
Patient Management Agent of the schedule. After the
examination is completed, the technician makes the record of
the result. With the help of Medical Examination Agent, the
examination report is generated and delivered to the doctor and
Patient Management Agent. Based on the report , the doctor
may input relevant data to the Clinical Decision Agent and
activate the risk evaluation process. The evaluation result is
then generated by Clinical Decision Agent and reported to the
doctor.
t3ifflM'·&#bf.WHij,!
V. IMPLEMENTATION
In our system, five agents are developed, Patient
Management Agent, Medical Examination Agent, Ward
Treatment Agent, Operation Agent, and Clinical Decision
Agent. For implementation of a multi-agent system, there are
various choices ofmulti-agent platforms. JADE [6] is a widely
used open source middleware developed by TILAB for the
development of distributed multi-agent applications based on
the peer-to-peer communication architecture. JADE is fully
supportive of the Foundation for Intelligent Physical Agents
(FIPA) specification. Messages exchanged by JADE agents
have a format specified using the Agent Communication
Language (ACL) defined by the FIPA international standard
for agent interoperability.
In addition to multi-agent architecture, the implementation
concerns the individual agent. After specifying clinical
guidelines and process rules using Protege, we use a plug-in
called beangenerator, implemented by C.J. van Aart, to create
the ontology definition class and the predicates, agent actions,
and concepts classes [2] for implementation ofindividual agent.
Agents can retrieve information and knowledge to perform
tasks under control ofrules or guidelines. Two types ofrules are
specified, one for clinical decision and another for
administrative process control.
In our system, the agents are required to perform individual
and collaborative tasks with other agents or human users
throughout the healthcare process. The scenario of risk level
evaluation , in the POAG treatment after topical therapy (see
Fig. 3) is used as an example to outline the sequence of
communication in the process. After the initial topical
treatment fails to achieve the pressure goal, the rule-based
POAG treatment algorithm triggers the next step of risk level
evaluation , during which the Clinical Decision Agent may
request the information about C/D ratio and/or Field loss level
for evaluation. The details of how the software agents and
human users communicate during this process are outlined as
follows.
As shown in Fig. 5, the sequence of communication
includes a number ofsteps. After the doctor inputs the result of
the initial topical therapy, the Clinical Decision Agent returns
the advice ofrisk level evaluation due to the poor result of the
initial topical treatment. After the doctor accepts the advice,
Clinical Decision Agent requests additional data (e.g., C/D
ratio) for risk level evaluation . Accordingly, the doctor sends
the examination request to the Medical Examination Agent,
and then some types ofavailable test are suggested by the agent.
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Fig.6. Profile ofRecommendation
Fig.6 depicts a screenshot of the prototype. The screen
contains: a) basic information of a patient such as the name,
gender, age, medical order, and history; b) diagnosis
information on lOP test such as inflammation, injury, open
angle, slip lamp test, goniosocopy, disc photo, and visual field
test; and c) initial treatment information including medication
records, laser therapy, CAlor additional treatment, and
filtration surgery. Based on the information and relevant
clinical guidelines, some recommendations are generate and
presented.
VI. CONCLUSION AND FUTURE WORK
This paper has presented a three-layer architecture of an
agent-based healthcare process management system. The
agent-based cognitive approach is applied to facilitate dynamic
and interactive processes in healthcare management. The
treatment of primary open angle glaucoma is used as an
example for demonstration. After the implementation of the
prototype, we will evaluate the effectiveness ofthe approach in
terms of support for clinical and administrative process
management in healthcare environment. Relevant clinical and
administrative staffwill be invited to use this system and give
feedback and evaluation on the system.
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